Apellis Pharmaceuticals (NASDAQ:APLS) Issues Quarterly Earnings Results, Misses Estimates By $0.14 EPS

Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.14), Briefing.com reports. Apellis Pharmaceuticals had a negative return on equity of 138.32% and a negative net margin of 52.99%. The business had revenue […]

Leave a Reply

Your email address will not be published.

Previous post Insider Selling: Agilysys, Inc. (NASDAQ:AGYS) Director Sells 500 Shares of Stock
Next post Henry Schein (NASDAQ:HSIC) Announces Quarterly Earnings Results